Search Results 791-800 of 16387 for monoclonal antibody

  1. A Study of CMB305 and Atezolizumab in Patients with Sarcoma - Mayo Clinic

    ... monoclonal antibodies, fusion proteins, or CHO cell products. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

  2. Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a ... monoclonal antibody with the exception of blinatumomab; patients must have ...

  3. MEETING THE CHALLENGES OF A HISTORIC YEAR: 2020 Mayo Clinic Performance Highlights

    ... monoclonal antibody treatments than any other health care organization, demonstrating a significant decrease in hospitalization rates and mortality.

  4. Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 - Mayo Clinic

    infusion reaction or hypersensitivity (CTCAE Grade 3 or higher) with monoclonal antibody treatment - Clinically significant cardiac disease, including but ...

  5. Science Saturday: Autoimmune disorders unmasked - Mayo Clinic News Network

    In response to infection or cancer, immune system cells create a molecule called an antibody. Antibodies latch onto specific cell proteins and signal to the ...

  6. Cholangiocarcinoma Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Cobimetinib may stop the growth of tumor ...

  7. Publications - Regan N. Theiler, M.D., Ph.D. - Mayo Clinic

    Vertical Transmission of SARS-CoV-2-Specific Antibodies and Cytokine Profiles in Pregnancy. ... Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild ...

  8. Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine - Mayo Clinic

    Receipt of any monoclonal antibody treatment (within or outside a clinical trial) within 6 months before screening. Previously dosed with ALD403 or any ...

  9. Neurology - Clinical trials - Mayo Clinic

    Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the body's immune system attack the cancer and may interfere with the ...

  10. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    0) hypersensitivity reactions to monoclonal antibodies, or history of anaphylaxis. Vaccination within 28 days of the first dose of study drugs and while on ...